Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) CEO Robert Barrow sold 15,502 shares of Mind Medicine (MindMed) stock in a transaction that occurred on Tuesday, June 27th. The shares were sold at an average price of $3.20, for a total value of $49,606.40. Following the sale, the chief executive officer now directly owns 623,457 […]
MindMed’s (NASDAQ: MNMD) heated proxy battle over R&D strategy might finally be coming to an end.
Longacre Square Partners guided Mind Medicine as the psychedelic drug company declared victory in its proxy contest.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), today announced that, based upon a preliminary vote assessment, shareholders have elected all six of the Company’s nominees – CEO ...
Believes Socially Responsible Investment Principles Support FCM’s Plan to Bring MM-120 To the Market in 2026 to Benefit Millions with Mental Health...